Vedana Therapeutics
Developing new therapies for migraine prevention.
Biotechnology
📍 Seattle, WA
Current Valuation
Private
PRIVATE
Developing new therapies for migraine prevention. Headquartered in Seattle, WA. Raised $46M in Series A funding in June 2026 led by Westlake BioPartners.
Company Profile
Last Round
Series A — $46M (Jun 2026) · Lead: Westlake BioPartners
Fundraising Status
Series A · $46M · this month
privateTotal raised $46M1 disclosed rounds
Funding History
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series A | $46M | Jun 2026 | Westlake BioPartners | — |
Investors
Westlake BioPartners · Canaan Partners · Dawn Biopharma · Alexandria Venture Investments
BiotechnologyTherapeuticsRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.